May 2014 tender notification
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and 2013/14 Invitation to Tender, dated 07 November 2013.
Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms and Pharmacodes
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website.
Where a product does not have a current Pharmacode, suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand before the 12th of the month prior to the date of listing. PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.
2012/13 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2016
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Current subsidy and (price) | New subsidy and price | Sole supply brand (Supplier) | Date of subsidy change | Sole Subsidised Supply date |
|---|---|---|---|---|---|---|
| Tranexamic acid | tab 500 mg; 100 tablet, bottle pack |
$32.92 | $23.00 | Cyklokapron (Pfizer) |
1 August 2014 | 1 November 2014 |
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
Tenders awarded to listed pharmaceuticals where only the current brand is listed.
The decisions were as follows:
| Tranexamic acid | tab 500 mg; 100 tablet, bottle pack |
$32.92 | $23.00 | Cyklokapron (Pfizer) |
1% | 1 August 2014 | 1 October 2014 |
| Chemical Name | Presentation; Pack size and type |
Current pack price | New pack price | Hospital Supply Brand (Supplier) |
DV Limit |
Date of price change | Hospital Supply Status date |
|---|
2013/14 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2017
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
Tenders awarded to pharmaceuticals where at least one other brand or pack size is listed.
The decisions were as follows:
| Chemical Name | Presentation; Pack size and type | Current subsidy and (price) | New subsidy and price | Sole supply brand (Supplier) |
Date of listing/subsidy change for tender winning brand | Date of reference pricing of other listed brands | Sole Subsidised Supply date (and delisting of other listed brands) | Brand (Supplier) affected by reference pricing and delisting |
|---|---|---|---|---|---|---|---|---|
| Amitriptyline 1 | tab 25 mg; 100 tablet, blister pack |
$1.85 | $1.68 | Arrow-Amitriptyline (Actavis) |
1 October 2014 | 1 December 2014 | 1 March 2015 | Amitrip (Mylan) |
| Amitriptyline 1 | tab 50 mg; 100 tablet, blister pack |
$3.60 | $2.82 | Arrow-Amitriptyline (Actavis) |
1 October 2014 | 1 December 2014 | 1 March 2015 | Amitrip (Mylan) |
| Amorolfine | nail soln 5%; 5 ml OP, bottle pack |
$37.86 ($61.87) |
$19.95 | MycoNail (AFT) |
1 November 2014 | 1 January 2015 | 1 April 2015 | Loceryl (Healthcare Logistics) |
| Imiquimod | crm 5%, 250 mg sachet; 12 sachets |
$62.00 | $17.98 | Apo-Imiquimod Cream 5% (Apotex) |
1 December 2014 | 1 February 2015 | 1 May 2015 | Aldara (Valeant) |
| Octreotide | inj 50 mcg per ml, 1 ml vial; 5 vials |
$19.24 | $13.50 | DBL (Hospira) |
1 July 2014 | 1 September 2014 | 1 December 2014 | Octreotide MaxRx (Max Health) |
| Octreotide | inj 100 mcg per ml, 1 ml vial; 5 vials |
$36.38 | $22.40 | DBL (Hospira) |
1 July 2014 | 1 September 2014 | 1 December 2014 | Octreotide MaxRx (Max Health) |
| Octreotide | inj 500 mcg per ml, 1 ml vial; 5 vials |
$131.25 | $89.40 | DBL (Hospira) |
1 July 2014 | 1 September 2014 | 1 December 2014 | Octreotide MaxRx (Max Health) |
| + Olanzapine 2 | tab orodispersible 5 mg; 28 tablet, blister pack |
$6.36 | $1.75 | Zypine ODT (Mylan) |
1 July 2014 | 1 September 2014 | 1 December 2014 | Olanzine-D (Mylan) Dr Reddy’s Olanzapine (Dr Reddy’s) Zyprexa Zydis (Eli Lilly) |
| + Olanzapine 2 | tab orodispersible 10 mg; 28 tablet, blister pack |
$8.76 | $3.05 | Zypine ODT (Mylan) |
1 July 2014 | 1 September 2014 | 1 December 2014 | Olanzine-D (Mylan) Dr Reddy’s Olanzapine (Dr Reddy’s) Zyprexa Zydis (Eli Lilly) |
| + Olanzapine 2 | tab 2.5 mg; 28 tablet, blister pack |
$2.00 | $0.75 | Zypine (Mylan) |
1 July 2014 | 1 September 2014 | 1 December 2014 | Dr Reddy’s Olanzapine (Dr Reddy’s) Zyprexa (Eli Lilly) |
| + Olanzapine 2 | tab 5 mg; 28 tablet, blister pack |
$3.85 | $1.65 | Zypine (Mylan) |
1 July 2014 | 1 September 2014 | 1 December 2014 | Olanzine (Mylan) Dr Reddy’s Olanzapine (Dr Reddy’s) Zyprexa (Eli Lilly) |
| + Olanzapine 2 | tab 10 mg;
28 tablet, blister pack |
$6.35 | $2.55 | Zypine (Mylan) | 1 July 2014 | 1 September 2014 | 1 December 2014 | Olanzine
(Mylan) Dr Reddy’s Olanzapine (Dr Reddy’s) Zyprexa (Eli Lilly) |
| Paracetamol with codeine | tab paracetamol 500 mg with codeine phosphate 8 mg;
1,000 tablet, blister pack |
$2.70 per 100 tablets | $21.06 per 1,000 tablets |
Paracetamol + Codeine (Relieve) (Mylan) |
1 October 2014 | 1 December 2014 | 1 March 2015 | Paracetamol + Codeine (Relieve) (Mylan)- 100 tablet packsize |
| + Quetiapine 2 | tab 25 mg; 90 tablet, blister pack |
$10.50 per 90 tablets | $2.10 per 90 tablets | Quetapel (Mylan) |
1 July 2014 | 1 September 2014 | 1 December 2014 | Dr Reddy’s Quetiapine (Dr Reddy’s) Seroquel (AstraZeneca) |
| + Quetiapine 2 | tab 100 mg; 90 tablet, blister pack |
$21.00 per 90 tablets | $4.20 per 90 tablets | Quetapel (Mylan) |
1 July 2014 | 1 September 2014 | 1 December 2014 | Dr Reddy’s Quetiapine (Dr Reddy’s) Seroquel (AstraZeneca) |
| + Quetiapine 2 | tab 200 mg; 90 tablet, blister pack |
$36.00 per 90 tablets | $7.20 per 90 tablets | Quetapel (Mylan) |
1 July 2014 | 1 September 2014 | 1 December 2014 | Dr Reddy’s Quetiapine (Dr Reddy’s) Seroquel (AstraZeneca) |
| + Quetiapine 2 | tab 300 mg; 90 tablet, blister pack |
$60.00 per 90 tablets | $12.00 per 90 tablets | Quetapel (Mylan) |
1 July 2014 | 1 September 2014 | 1 December 2014 | Dr Reddy’s Quetiapine (Dr Reddy’s) Seroquel (AstraZeneca) |
| + Risperidone 2 | oral liq1 mg per ml; 30 ml, bottle pack |
$18.35 | $9.75 | Risperon (Mylan) |
1 July 2014 | 1 September 2014 | 1 December 2014 | Apo-Risperidone (Apotex) Risperdal (Janssen-Cilag) |
| + Risperidone 3 | tab 0.5 mg; 60 tablet, blister pack |
$3.51 per 60 tablet | $1.90 per 60 tablet | Risperidone (Actavis) |
1 October 2014 | 1 February 2015 | 1 May 2015 | Apo-Risperidone (Apotex) Dr Reddy’s Risperidone (Dr Reddy’s) Ridal (Douglas) Risperdal (Janssen-Cilag) |
| + Risperidone 3 | tab 1 mg; 60 tablet, blister pack |
$6.00 per 60 tablet | $2.10 per 60 tablet | Risperidone (Actavis) |
1 October 2014 | 1 February 2015 | 1 May 2015 | Apo-Risperidone (Apotex) Dr Reddy’s Risperidone (Dr Reddy’s) Ridal (Douglas) Risperdal (Janssen-Cilag) |
| + Risperidone 3 | tab 2 mg; 60 tablet, blister pack |
$11.00 per 60 tablet | $2.34 per 60 tablet | Risperidone (Actavis) |
1 October 2014 | 1 February 2015 | 1 May 2015 | Apo-Risperidone (Apotex) Dr Reddy’s Risperidone (Dr Reddy’s) Ridal (Douglas) Risperdal (Janssen-Cilag) |
| + Risperidone 3 | tab 3 mg; 60 tablet, blister pack |
$15.00 per 60 tablet | $2.55 per 60 tablet | Risperidone (Actavis) |
1 October 2014 | 1 February 2015 | 1 May 2015 | Apo-Risperidone (Apotex) Dr Reddy’s Risperidone (Dr Reddy’s) Ridal (Douglas) Risperdal (Janssen-Cilag) |
| + Risperidone 3 | tab 4 mg;
60 tablet, blister pack |
$20.00 per 60 tablet | $3.50 per 60 tablet | Risperidone (Actavis) |
1 October 2014 | 1 February 2015 | 1 May 2015 | Apo-Risperidone (Apotex) Dr Reddy’s Risperidone (Dr Reddy’s) Ridal (Douglas) Risperdal (Janssen-Cilag) |
+ We will be providing more information about the antipsychotic changes for clinicians, consumers, pharmacies and caregivers over the coming months
|
||||||||
Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Current subsidy and (price) | New subsidy and price | Sole supply brand (Supplier) | Date of subsidy change | Sole Subsidised Supply date |
|---|---|---|---|---|---|---|
| Amitriptyline | tab 10 mg; 100 tablet, blister pack |
$3.32 | $1.68 | Arrow-Amitriptyline (Actavis) |
1 July 2014 | 1 October 2014 |
| Calcium carbonate | tab 1.25 g (500 mg elemental); 250 tablet, bottle pack |
$6.38 | $5.38 | Arrow-Calcium (Actavis) |
1 July 2014 | 1 October 2014 |
| Fluconazole | cap 50 mg; 28 capsule, blister pack |
$4.77 | $3.49 | Ozole (Douglas) |
1 September 2014 | 1 December 2014 |
| Fluconazole | cap 150 mg; 1 capsule, blister pack |
$0.91 | $0.71 | Ozole (Douglas) |
1 September 2014 | 1 December 2014 |
| Fluconazole | cap 200 mg; 28 capsule, blister pack |
$13.34 | $9.69 | Ozole (Douglas) |
1 September 2014 | 1 December 2014 |
| Ipratropium bromide | aqueous nasal spray, 0.03%; 15 ml, vial |
$4.03 | $3.95 | Univent (Rex Medical) |
1 November 2014 | 1 February 2015 |
| Lidocaine [lignocaine] hydrochloride | oral (viscous) soln 2%; 200 ml, bottle pack |
$55.00 | $55.00 | Xylocaine Viscous (AstraZeneca) |
1 July 2014 | 1 October 2014 |
| Pethidine hydrochloride | inj 50 mg per ml, 1 ml; 5 ampoules |
$5.51 | $5.51 | DBL Pethidine Hydrochloride (Hospira) |
1 July 2014 | 1 October 2014 |
| Pethidine hydrochloride | inj 50 mg per ml, 2 ml; 5 ampoules |
$5.83 | $5.83 | DBL Pethidine Hydrochloride (Hospira) |
1 July 2014 | 1 October 2014 |
| Simvastatin | tab 10 mg; 90 tablet, blister pack |
$1.40 | $0.95 | Arrow-Simva 10mg (Actavis) |
1 July 2014 | 1 October 2014 |
| Simvastatin | tab 20 mg; 90 tablet, blister pack |
$1.95 | $1.61 | Arrow-Simva 20mg (Actavis) |
1 July 2014 | 1 October 2014 |
| Simvastatin | tab 40 mg; 90 tablet, blister pack |
$3.18 | $2.83 | Arrow-Simva 40mg (Actavis) |
1 July 2014 | 1 October 2014 |
| Simvastatin | tab 80 mg; 90 tablet, blister pack |
$9.31 | $7.91 | Arrow-Simva 80mg (Actavis) |
1 July 2014 | 1 October 2014 |
Tenders awarded to pharmaceuticals where no brand is listed.
The decisions were as follows:
| Chemical Name | Presentation; Pack size and type |
Pack price | Sole supply brand (Supplier) | Listing date | Sole Subsidised Supply date |
|---|---|---|---|---|---|
| Granisetron * | tab 1 mg; 50 tablet, blister pack |
$5.98 | Granirex (Rex Medical) |
1 November 2014 | 1 February 2015 |
| *Stat dispensing will apply to this product | |||||
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
Tenders awarded to pharmaceuticals where at least one other brand or pack size is listed.
The decisions were as follows:
| Chemical Name | Presentation; Pack size and type |
Current pack price | New pack price |
Hospital Supply Brand (Supplier) |
DV Limit |
Date of listing/price change for tender winning brand | Hospital Supply Status date (and delisting of other listed brands) | Brand (Supplier) to be delisted |
|---|---|---|---|---|---|---|---|---|
| Amitriptyline | tab 25 mg; 100 tablet, blister pack |
$1.85 | $1.68 | Arrow-Amitriptyline (Actavis) |
1% | 1 October 2014 | 1 December 2014 | Amitrip (Mylan) |
| Amitriptyline | tab 50 mg; 100 tablet, blister pack |
$3.60 | $2.82 | Arrow-Amitriptyline (Actavis) |
1% | 1 October 2014 | 1 December 2014 | Amitrip (Mylan) |
| *Amorolfine | nail soln 5%; 5 ml, bottle pack |
$37.86 | $19.95 | MycoNail (AFT) |
1% | 1 November 2014 | 1 January 2015 | Loceryl (Healthcare Logistics) |
| Imiquimod | crm 5%, 250 mg sachet; 12 sachets |
$62.00 | $17.98 | Apo-Imiquimod Cream 5% (Apotex) |
1% | 1 December 2014 | 1 February 2015 | Aldara (Valeant) |
| Octreotide | inj 50 mcg per ml, 1 ml vial; 5 vials |
$19.24 | $13.50 | DBL (Hospira) |
1% | 1 July 2014 | 1 September 2014 | Octreotide MaxRx (Max Health) |
| Octreotide | inj 100 mcg per ml, 1 ml vial; 5 vials |
$36.38 | $22.40 | DBL (Hospira) |
1% | 1 July 2014 | 1 September 2014 | Octreotide MaxRx (Max Health) |
| Octreotide | inj 500 mcg per ml, 1 ml vial; 5 vials |
$131.25 | $89.40 | DBL (Hospira) |
1% | 1 July 2014 | 1 September 2014 | Octreotide MaxRx (Max Health) |
| + Olanzapine | tab orodispersible 5 mg; 28 tablet, blister pack |
$6.36 | $1.75 | Zypine ODT (Mylan) |
1% | 1 July 2014 | 1 September 2014 | Olanzine-D (Mylan) |
| + Olanzapine | tab orodispersible 10 mg; 28 tablet, blister pack |
$8.76 | $3.05 | Zypine ODT (Mylan) |
1% | 1 July 2014 | 1 September 2014 | Olanzine-D (Mylan) |
| + Olanzapine | tab 2.5 mg; 28 tablet, blister pack |
$2.00 | $0.75 | Zypine (Mylan) |
1% | 1 July 2014 | 1 September 2014 | Olanzine (Mylan) |
| + Olanzapine | tab 5 mg; 28 tablet, blister pack |
$3.85 | $1.65 | Zypine (Mylan) |
1% | 1 July 2014 | 1 September 2014 | Olanzine (Mylan) |
| + Olanzapine | tab 10 mg; 28 tablet, blister pack |
$6.35 | $2.55 | Zypine (Mylan) |
1% | 1 July 2014 | 1 September 2014 | Olanzine (Mylan) |
| Paclitaxel 1 | inj 6 mg per ml, 16.7 ml vial; 1 vial |
$91.67 | $19.02 | Paclitaxel Ebewe (Sandoz) |
1% | 1 July 2014 | 1 September 2014 | Paclitaxel Actavis (Actavis) |
| Paclitaxel 1 | inj 6 mg per ml, 25 ml vial; 1 vial |
$137.50 | $26.69 | Paclitaxel Ebewe (Sandoz) |
1% | 1 July 2014 | 1 September 2014 | Paclitaxel Actavis (Actavis) Anzatax (Hospira) |
| Paclitaxel 1 | inj 6 mg per ml, 50 ml via; 1 vial |
$275.00 | $36.53 | Paclitaxel Ebewe (Sandoz) |
1% | 1 July 2014 | 1 September 2014 | Paclitaxel Actavis (Actavis) Anzatax (Hospira) |
| + Quetiapine | tab 25 mg; 90 tablet, blister pack |
$10.50 per 90 tablets | $2.10 per 90 tablets | Quetapel (Mylan) |
1% | 1 July 2014 | 1 September 2014 | Dr Reddy’s Quetiapine (Dr Reddy’s) Seroquel (AstraZeneca) |
| + Quetiapine | tab 100 mg; 90 tablet, blister pack |
$21.00 per 90 tablets | $4.20 per 90 tablets | Quetapel (Mylan) |
1% | 1 July 2014 | 1 September 2014 | Dr Reddy’s Quetiapine (Dr Reddy’s) Seroquel (AstraZeneca) |
| + Quetiapine | tab 200 mg; 90 tablet, blister pack |
$36.00 per 90 tablets | $7.20 per 90 tablets | Quetapel (Mylan) |
1% | 1 July 2014 | 1 September 2014 | Dr Reddy’s Quetiapine (Dr Reddy’s) Seroquel (AstraZeneca) |
| + Quetiapine | tab 300 mg; 90 tablet, blister pack |
$60.00 per 90 tablets | $12.00 per 90 tablets | Quetapel (Mylan) |
1% | 1 July 2014 | 1 September 2014 | Dr Reddy’s Quetiapine (Dr Reddy’s) Seroquel (AstraZeneca) |
| + Risperidone | oral liq1 mg per ml; 30 ml, bottle pack |
$18.35 | $9.75 | Risperon (Mylan) |
1% | 1 July 2014 | 1 September 2014 | Apo-Risperidone (Apotex) Risperdal (Janssen-Cilag) |
| + Risperidone | tab 0.5 mg; 60 tablet, blister pack |
$3.51 per 60 tablet | $1.90 per 60 tablet | Risperidone (Actavis) |
1% | 1 October 2014 | 1 February 2015 | Apo-Risperidone (Apotex) Dr Reddy’s Risperidone (Dr Reddy’s) Ridal (Douglas) Risperdal (Janssen-Cilag) |
| + Risperidone | tab 1 mg; 60 tablet, blister pack |
$6.00 per 60 tablet | $2.10 per 60 tablet | Risperidone (Actavis) |
1% | 1 October 2014 | 1 February 2015 | Apo-Risperidone (Apotex) Dr Reddy’s Risperidone (Dr Reddy’s) Ridal (Douglas) Risperdal (Janssen-Cilag) |
| + Risperidone | tab 2 mg; 60 tablet, blister pack |
$11.00 per 60 tablet | $2.34 per 60 tablet | Risperidone (Actavis) |
1% | 1 October 2014 | 1 February 2015 | Apo-Risperidone (Apotex) Dr Reddy’s Risperidone (Dr Reddy’s) Ridal (Douglas) Risperdal (Janssen-Cilag) |
| + Risperidone | tab 3 mg; 60 tablet, blister pack |
$15.00 per 60 tablet | $2.55 per 60 tablet | Risperidone
(Actavis) |
1% | 1 October 2014 | 1 February 2015 | Apo-Risperidone (Apotex) Dr Reddy’s Risperidone (Dr Reddy’s) Ridal (Douglas) Risperdal (Janssen-Cilag) |
| + Risperidone | tab 4 mg; 60 tablet, blister pack |
$20.00 per 60 tablet | $3.50 per 60 tablet | Risperidone (Actavis) |
1% | 1 October 2014 | 1 February 2015 | Apo-Risperidone (Apotex) Dr Reddy’s Risperidone (Dr Reddy’s) Ridal (Douglas) Risperdal (Janssen-Cilag) |
|
*Restrictions which currently apply for this product will be removed from 1 Novemeber 2014 + We will be providing more information about the antipsychotic changes for clinicians, consumers, pharmacies and caregivers over the coming months 1. The price and subsidy of paclitaxel (PCT – Retail Pharmacy Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 July 2014. The subsidy for paclitaxel inj 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $1.02 per 1 mg to $0.17 per 1 mg from 1 July 2014 |
||||||||
Tenders awarded to listed pharmaceuticals where only the current brand is listed.
The decisions were as follows:
| Amitriptyline | tab 10 mg; 100 tablet, blister pack |
$3.32 | $1.68 | Arrow-Amitriptyline (Actavis) |
1% | 1 July 2014 | 1 September 2014 |
| Fluconazole | cap 50 mg; 28 capsule, blister pack |
$4.77 | $3.49 | Ozole (Douglas) |
1% | 1 September 2014 | 1 November 2014 |
| Fluconazole | cap 200 mg; 28 capsule, blister pack |
$13.34 | $9.69 | Ozole (Douglas) |
1% | 1 September 2014 | 1 November 2014 |
| Paclitaxel 1 | inj 6 mg per ml, 5 ml vial; 5 vials |
$137.50 | $45.00 | Paclitaxel Ebewe (Sandoz) |
1% | 1 July 2014 | 1 September 2014 |
| Calcium carbonate | tab 1.25 g (500 mg elemental); 250 tablet, bottle pack |
$6.38 | $5.38 | Arrow-Calcium (Actavis) |
1% | 1 July 2014 | 1 September 2014 |
| Lidocaine [lignocaine] hydrochloride | oral (viscous) soln 2%; 200 ml, bottle pack |
$55.00 | $55.00 | Xylocaine Viscous (AstraZeneca) |
1% | 1 July 2014 | 1 September 2014 |
| Pethidine hydrochloride | inj 50 mg per ml, 1 ml; 5 ampoules |
$5.51 | $5.51 | DBL Pethidine Hydrochloride (Hospira) |
1% | 1 July 2014 | 1 September 2014 |
| Simvastatin | tab 10 mg; 90 tablet, blister pack |
$1.40 | $0.95 | Arrow-Simva 10mg (Actavis) |
1% | 1 July 2014 | 1 September 2014 |
| Simvastatin | tab 40 mg;
90 tablet, blister pack |
$3.18 | $2.83 | Arrow-Simva 40mg (Actavis) |
1% | 1 July 2014 | 1 September 2014 |
| Fluconazole | cap 150 mg; 1 capsule, blister pack |
$0.91 | $0.71 | Ozole (Douglas) |
1% | 1 September 2014 | 1 November 2014 |
| Pethidine hydrochloride | inj 50 mg per ml, 2 ml; 5 ampoules |
$5.83 | $5.83 | DBL Pethidine Hydrochloride (Hospira) |
1% | 1 July 2014 | 1 September 2014 |
| Simvastatin | tab 80 mg;
90 tablet, blister pack |
$9.31 | $7.91 | Arrow-Simva 80mg (Actavis) |
1% | 1 July 2014 | 1 September 2014 |
| Paclitaxel 1 | inj 6 mg per ml, 100 ml vial; 1 vial | $550.00 | $73.06 | Paclitaxel Ebewe (Sandoz) |
1% | 1 July 2014 | 1 September 2014 |
| Simvastatin | tab 20 mg; 90 tablet, blister pack |
$1.95 | $1.61 | Arrow-Simva 20mg
(Actavis) |
1% | 1 July 2014 | 1 September 2014 |
| 1. The price and subsidy of paclitaxel (PCT – Retail Pharmacy Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 July 2014. The subsidy for paclitaxelinj 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $1.02 per 1 mg to $0.17 per 1 mg from 1 July 2014 | |||||||
| Chemical Name | Presentation; Pack size and type |
Current pack price | New pack price | Hospital Supply Brand (Supplier) |
DV Limit |
Date of price change | Hospital Supply Status date |
|---|---|---|---|---|---|---|---|
Tenders awarded to pharmaceuticals where no brand is listed.
The decisions were as follows:
| Chemical Name | Presentation; Pack size and type |
Pack price | Hospital Supply Brand (Supplier) |
DV Limit |
Listing date | Hospital Supply Status date |
|---|---|---|---|---|---|---|
| Alfentanil | inj 0.5 mg per ml, 2 ml ampoule; 10 ampoules |
$39.07 | Hameln (Max Health) |
1% | 1 November 2014 | 1 January 2015 |
| Atovaquone with proguanil hydrochloride | tab 62.5 mg with proguanil hydrochloride 25 mg; 12 tablet |
$25.00 | Malarone Junior (GSK) |
1% | 1 September 2014 | 1 November 2014 |
| Atovaquone with proguanil hydrochloride | tab 250 mg with proguanil hydrochloride 100 mg; 12 tablet |
$64.00 | Malarone (GSK) |
1% | 1 September 2014 | 1 November 2014 |
| Granisetron | tab 1 mg; 50 tablet, blister pack |
$5.98 | Granirex (Rex Medical) |
1% | 1 November 2014 | 1 January 2015 |
| Ipratropium bromide | aqueous nasal spray, 0.03%; 15 ml, vial |
$3.95 | Univent (Rex Medical) |
1% | 1 November 2014 | 1 January 2015 |
| Ketamine | inj 1 mg per ml, 100 ml bag | $27.00 | Biomed (Biomed) | 1% | 1 July 2014 | 1 September 2014 |
| Ketamine | inj 4 mg per ml, 50 ml syringe | $25.00 | Biomed (Biomed) | 1% | 1 July 2014 | 1 September 2014 |
| Ketamine | inj 10 mg per ml, 10 ml syringe | $14.00 | Biomed (Biomed) | 1% | 1 July 2014 | 1 September 2014 |
Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status
PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2012/13 Invitation to Tender, dated 31 October 2012 and 2013/14 Invitation to Tender, dated 07 November 2013:
2013/14 Invitation to Tender
| Chemical Name | Line Item |
|---|---|
| Isosorbide mononitrate | Tab long-acting 60 mg |
| Bupivacaine hydrochloride with fentanyl | Inj 0.625 mg with fentanyl 2 mcg per ml, 100 ml bag |
| Bupivacaine hydrochloride with fentanyl | Inj 1.25mg with 2 mcg fentanyl per ml, 15 ml syringe |
| Bupivacaine hydrochloride with fentanyl | Inj 1.25mg with 2 mcg fentanyl per ml, 20 ml syringe |
| Bupivacaine hydrochloride with fentanyl | Inj 1.25 mg with fentanyl 2 mcg per ml, 50 ml syringe |
| Bupivacaine hydrochloride with fentanyl | Inj 1.25 mg with fentanyl 2 mcg per ml, 100 ml syringe |
| Bupivacaine hydrochloride with fentanyl | Inj 1.25mg with 2 mcg fentanyl per ml, 100 ml bag |
| Bupivacaine hydrochloride with fentanyl | Inj 1.25mg with 2 mcg fentanyl per ml, 200 ml bag |
| Calcium carbonate | tab eff 0.875 - 1.75 g (0.5 g - 1 g elemental) |
| Fentanyl | inj 10 mcg per ml, 10 ml syringe |
| Fentanyl | inj 10 mcg per ml, 50 ml prefilled syringe |
| Fentanyl | inj 20 mcg per ml, 50 ml prefilled syringe |
| Fentanyl | inj 10 mcg per ml, 50 ml premixed bag |
| Fentanyl | inj 10 mcg per ml, 100 ml premixed bag |
| Fentanyl | inj 20 mcg per ml, 100 ml bag |
| Granisetron | Tab 2 mg |
| Hyoscine N-butylbromide | Inj 20 mg, 1 ml |
| Lidocaine [lignocaine] hydrochloride | Oral [viscous] soln 4% |
| Octreotide (somatostatin analogue) | LAR inj 10 mg |
| Octreotide (somatostatin analogue) | LAR inj 20 mg |
| Octreotide (somatostatin analogue) | LAR inj 30 mg |
| Quetiapine | Tab 12.5 mg |
PHARMAC has resolved not to award tenders for Hospital Supply Status for the following products listed in the 2013/14 Invitation to Tender, dated 07 November 2013:
| Chemical Name | Line Item |
|---|---|
| Paracetamol with codeine | tab paracetamol 500 mg with codeine phosphate 8 mg |
For products included in the 2011/12 Invitation to Tender, 2012/13 or the 2013/14 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.
If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.